To investigate the relationship between ACE2 expression in plasma and clinical prognostic parameters of breast cancer, we chose the median value of ACE2 expression as the cutoff value and divided the samples into ACE2 high and low groups (Table 4). Here, ACE2 is linked to breast carcinoma.